Neurology
Conference Coverage
General neurologists lag on prescribing high-efficacy MS drugs
SEATTLE – Single-system study suggests that MS subspecialists are more willing than are general neurologists to embrace the newer MS drugs.
FDA/CDC
FDA approves Zolgensma for infantile-onset SMA treatment
Zolgensma is the first gene therapy for the treatment of infantile-onset spinal muscular atrophy in children aged less than 2 years.
News
Elderly concussion patients who used statins had lower dementia risk
However, the subsequent incidence of dementia was still twice the population norm in statin users who had concussions.
News
Stroke policy recommendations incorporate advances in endovascular therapy
For stroke patients with a suspected large vessel occlusion, emergency medical services should consider up to 15 minutes of additional travel time...
Conference Coverage
Green light therapy: A stop sign for pain?
MILWAUKEE – Pain scores and opioid use may plummet with the noninvasive therapy.
Conference Coverage
Insomnia symptoms correlate with seizure frequency
PHILADELPHIA – Nearly a quarter of adults with epilepsy have moderate or severe insomnia, and insomnia symptoms are associated with depression,...
Conference Coverage
More than one in six patients with status epilepticus are readmitted after hospital discharge
PHILADELPHIA – Identifying patients at high risk of readmission could reduce their financial and clinical burdens....
Conference Coverage
Experts discuss what’s new in migraine treatment
PHILADELPHIA – Dr. Alan Rapoport asks Dr. Stewart Tepper to summarize some of
Conference Coverage
Appendectomy linked to increased risk of subsequent Parkinson’s
The findings give pause to the notion of performing discretionary appendectomies in patients who are having surgery for another reason.
FDA/CDC
Insomnia meds get boxed warning from FDA
Although complex sleep behaviors, such as sleep walking, associated with these medications are rare, the consequences can be deadly.